What ESMS does

ESMS Global Limited is a London-headquartered, UK private limited company that provides specialist 24/7 medical response and information services to the clinical trials industry. The company originated in 1963 as the Medical Toxicology and Information Service within the poisons unit of Guy's Hospital London, transitioned to a dedicated clinical trials services division in 1996, was incorporated as a private limited company in 2011, and has supported more than 300 studies covering 110,000 patients across 80 countries. Its core offerings include Global Emergency Unblinding, Serious Breach Reporting (mandated by 2023 EMA legislation), Direct-to-Patient Helpline, Participant Onboarding, Medical Information, and Medical Monitoring services, all delivered through in-country telephone lines, multilingual interpretation in 45+ languages, and validated computer systems compatible with any Interactive Response Technology (IRT) platform.

ESMS generates revenue primarily through recurring subscription-style service fees, with multi-year contracts and tiered offerings (dedicated telephone lines, shared lines, or centralized ESMS line for smaller organizations). Pricing is quote-based and not publicly disclosed. The company goes to market through direct enterprise sales, dedicated account management, industry-conference presence (OCT, COG, DIA, PIPA, ResearchDF), and content marketing via case studies and surveys. It serves three primary segments — large and mid-sized pharmaceutical companies, contract research organizations (CROs), and biotechnology companies — plus a secondary segment of academic and public research institutions. Logo customers include Boehringer Ingelheim, Bayer, Astellas, LEO Pharma, Destiny Pharma, Beckley Psytech, VIVUS, Britannia Pharmaceuticals, Warwick Clinical Trials, and CPC Clinical.

The underlying technology stack combines validated computer systems, validated call recording, IRT-agnostic integration, and a regularly tested disaster recovery infrastructure. A differentiating structural element is the company's association with Guy's and St Thomas' NHS Foundation Trust, providing access to practicing Senior Consultant Physicians who join emergency calls within 15 minutes, alongside a strategic partnership with Almac (IXRS/IRT) that allows sponsors to integrate unblinding response with their trial management systems. The company holds ISO 9001 certification (since 2013), operates under ICH GCP, PIPA Guidelines, and the ABPI Code of Practice, and has passed MHRA GCP inspection.

Name

ESMS

Legal name

ESMS Global Ltd

Website

https://esmsglobal.com

Company type

Private

Founded year

1963

Operating status

Operating

Headcount range

51–100 employees

Short description

ESMS Global provides 24/7 emergency medical response, unblinding, serious breach reporting, and medical information services for clinical trials. It serves pharmaceutical, biotech, CRO, and academic clients across 80 countries, with multilingual coverage in 45+ languages.

Ownership category

akta.pro rank

Product category

Clinical Trial Support Services

NAICS

Telephone Call Centers (56142), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Clinical Trial Management Systems (CTMS) (HLACAOAD)

Keywords

• Clinical trial services
• Emergency unblinding
• Medical information services
• Pharmacovigilance support
• Patient helpline services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Support Services: Recurring service fees for 24/7 emergency unblinding, medical monitoring, and helpline services. Flexible models include dedicated telephone lines (secured solely for client use) or shared lines for cost-efficiency. Supports portfolio of studies across multiple countries.
2. Medical Information Services: Tailored enquiry management contact centre services for licensed pharmaceutical products. Flexible models including full service/out of hours, shared/dedicated model, single/multiple products. Includes literature searching, complex response writing, and standard response maintenance.
3. Telecommunications Services: Dedicated telephone lines for client portfolios; shared telephone lines for smaller/local studies; centralized ESMS line for small to mid-sized organisations; integration into current client telecom solutions.
4. Patient Recruitment and Onboarding Services: Services managing enquiries from trial registries including clinicaltrials.gov, handling enrolment requests, compassionate use requests, and pre-screening eligibility questionnaires.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels11 records

Core offering

ESMS Global provides specialist 24/7/365 clinical trial support services to pharmaceutical, biotechnology, and CRO clients, including emergency unblinding, serious breach reporting, direct-to-patient helplines, participant onboarding, medical information, and medical monitoring. Services are backed by validated technology, multilingual capability across 45+ languages, and integration with client trial management systems. The company supports over 300 active studies and 110,000 patients across 80 countries.

Product overview

ESMS Global provides a unified suite of specialist services supporting clinical trials and medical information for the pharmaceutical industry. The core offering comprises a 24/7 emergency medical response service for clinical trials, which includes the Global Emergency Unblinding Service, Serious Breach Reporting Service, Direct to Patient Helpline, and Clinical Trials Participant Onboarding modules. These are supported by Medical Information Services (including Out-of-Hours support), Medical Monitoring with consultant physician access, and a Telephone Diary Support Service. The company also offers language translation support across 45 languages. All services operate on a 24/7/365 basis with ISO 9001 quality accreditation.

Differentiator

Problem solved

Functional benefit

Products and services

• Global Emergency Unblinding Service 24/7 emergency response service enabling authorized clinicians to rapidly unblind patients in clinical trials when medically necessary, supporting patient safety and regulatory compliance. Resolves approximately 95% of unblinding requests without actually performing unblinding, delivering significant cost savings.
• Serious Breach Reporting Service Dedicated helpline and email service for sponsors to report serious breaches in EMA-approved clinical trials, as mandated by EU Clinical Trial Regulation No. 536/2014.
• Clinical Trials Direct To Patient Helpline Single point of contact for patients requiring support with clinical trial companion apps and software (SaMD), including technical troubleshooting, data capture, and adverse event reporting.
• Clinical Trials Participant Onboarding Global enrollment support service triaging enquiries from trial registries including clinicaltrials.gov, managing pre-screening eligibility questionnaires, and facilitating site referrals.
• Medical Information Services 24/7 enquiry management contact centre providing medical information for licensed pharmaceutical products, including experienced pharmacists and information scientists for complex inquiry handling. Tailored service models including full service/out of hours, shared/dedicated, single/multiple products.
• Medical Monitoring Medical monitoring and response services during every trial stage to support subject participation and raise engagement and retention levels, with consultant physicians available 24/7.
• Telephone Diary Support Service Outbound telephone service collecting daily patient diary data across 28 countries in local languages, inputting data directly into eCRF on patients' behalf.

Quantifiable outcome

• 95% of unblinding requests resolved without performing actual unblinding, reducing significant expenditure on acquiring replacement patients
• +5 more outcomes

Named customers13 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• AlmaccoreStrategic or Co-development PartnerStrategic partnership between Almac's IXRS technology (Simplify and IXRS 3 IRT solutions) and ESMS Global's 24/7 emergency response services. In compliance with E6 Good Clinical Practice (GCP) regulations section 5.13, this partnership provides clinical trial sponsors immediate access to clinical assessment for emergency unblinding procedures to support patient safety even if Principal Investigator is not physically present. The combined solution enables 95% of calls where unblinding is requested to be resolved without actually performing unblinding. Rita Fitzpatrick (ESMS GM) and Val Higgins (Almac President & MD) publicly announced the collaboration.
• Guy's and St Thomas' NHS Foundation TrustcoreStrategic or Co-development PartnerESMS maintains a unique association with one of the world's leading teaching hospitals, Guy's and St Thomas' NHS Foundation Trust. This connection provides access to practicing Senior Physicians who join emergency calls within a maximum wait time of 15 minutes to provide emergency medical advice 24 hours a day, satisfying GCP requirements.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Parexel: Large CRO with dedicated medical information, pharmacovigilance, and patient safety services serving global pharma. Competes with ESMS for emergency response and medical monitoring contracts, typically bundled with larger trial engagements.
• Labcorp Drug Development (formerly Covance): Global CRO and central laboratory business providing clinical development, pharmacovigilance, and medical information services. Comparable to ESMS on safety/medical information but with significantly broader scope.
• SGS Health Sciences (SGS): Life sciences clinical research and pharmacovigilance services division of SGS, providing clinical trial and patient safety support. Comparable to ESMS in CRO-style patient safety and medical information services.
• IQVIA: World's largest CRO with broad pharmacovigilance, medical information, and patient safety services. Overlaps with ESMS on emergency unblinding and 24/7 medical response but competes as a full-service incumbent rather than a specialist.
• ICON plc: Global CRO offering medical communications, pharmacovigilance, and clinical trial services. Comparable to ESMS in medical information and safety reporting, but delivered as part of a much broader CRO portfolio.

Direct peers

• Ergomed (now part of Ergomed-CRO / acquired by private equity): Clinical research and pharmacovigilance services provider focused on specialized and orphan indications. Comparable to ESMS in serving niche trial support needs and emerging biotech sponsors.
• Worldwide Clinical Trials: Mid-sized global CRO offering medical monitoring, pharmacovigilance, and patient support across multiple therapeutic areas. Closely comparable to ESMS in scale, specialization, and target sponsor base.
• Almac Group: Clinical trial services and IXRS technology provider that is both a strategic partner and a competitor. Almac's clinical services arm offers comparable patient safety and trial support capabilities, while its IRT integration makes it the most direct peer in ESMS's core workflow.

Emerging players

• Clario (formerly ERT / BioTelemetry): Clinical trial technology vendor for eCOA, cardiac safety, and patient-centric trial solutions. Adjacent to ESMS in trial enablement, with potential overlap in decentralized trial patient support and SaMD troubleshooting.

Regional players

• Pharmaron: China-headquartered CRO with growing global clinical and safety services offering. Comparable in clinical trial support breadth, particularly for sponsors running trans-Pacific studies.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/esms-global
• Xx.com/EsmsGlobal

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ESMS